UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

The Lancet (British edition), 2020-10, Vol.396 (10257), p.1090-1100

2020

Volltextzugriff (PDF)

Trend in Cancer Incidence and Mortality in Fukushima From 2008 Through 2015

Journal of Epidemiology, 2021/12/05, Vol.31(12), pp.653-659

2021

Volltextzugriff (PDF)

Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network

International journal of cancer, 2018-12, Vol.143 (11), p.2905-2918

2018

Volltextzugriff (PDF)

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy

BMC cancer, 2015-10, Vol.15 (1), p.698-698, Article 698

2015

Volltextzugriff (PDF)

Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis

International journal of cancer, 2009-02, Vol.124 (3), p.698-712

2009

Volltextzugriff (PDF)

Evaluation of a novel medical device for pegfilgrastim administration

Cancer science, 2022-05, Vol.113 (5), p.1763-1770

2022

Volltextzugriff (PDF)

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial

Breast cancer research and treatment, 2022-02, Vol.191 (3), p.565-576

2022

Volltextzugriff (PDF)

Circulating cell-free DNA-based epigenetic assay can detect early breast cancer

Breast cancer research : BCR, 2016-12, Vol.18 (1), p.129-129, Article 129

2016

Volltextzugriff (PDF)

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition

Breast cancer (Tokyo, Japan), 2020-05, Vol.27 (3), p.322-331

2020

Volltextzugriff (PDF)

The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition

Breast cancer (Tokyo, Japan), 2020-01, Vol.27 (1), p.4-8

2020

Volltextzugriff (PDF)

Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy

Breast (Edinburgh), 2024-02, Vol.73, p.103604-103604, Article 103604

2024

Volltextzugriff (PDF)

Characteristics of adverse events of endocrine therapies among older patients with breast cancer

Supportive care in cancer, 2019-10, Vol.27 (10), p.3813-3822

2019

Volltextzugriff (PDF)

Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood-Brain Barrier Models

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3379

2024

Volltextzugriff (PDF)

Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3727-3734

2008

Volltextzugriff (PDF)

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

Scientific reports, 2019-09, Vol.9 (1), p.13343-8, Article 13343

2019

Volltextzugriff (PDF)

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition

Breast cancer (Tokyo, Japan), 2020-01, Vol.27 (1), p.9-16

2020

Volltextzugriff (PDF)

Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan

Breast cancer (Tokyo, Japan), 2021-01, Vol.28 (1), p.1-8

2021

Volltextzugriff (PDF)

Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells

Scientific reports, 2021-03, Vol.11 (1), p.5216-13, Article 5216

2021

Volltextzugriff (PDF)

CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study

Journal of clinical oncology, 2020-02, Vol.38 (6), p.558-566

2020

Volltextzugriff (PDF)

Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β

Breast cancer research : BCR, 2023-04, Vol.25 (1), p.41-41, Article 41

2023

Volltextzugriff (PDF)

Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-05, Vol.21 (3), p.429-438

2018

Volltextzugriff (PDF)

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer

BMC cancer, 2021-11, Vol.21 (1), p.1269-1269, Article 1269

2021

Volltextzugriff (PDF)

Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study

BMC cancer, 2017-06, Vol.17 (1), p.423-423, Article 423

2017

Volltextzugriff (PDF)

1 – 25 von 316

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(293)
Mit Volltextzugriff
(271)

Publikationsform

Artikel
(315)
Berichte
(1)

Sprache

Englisch
(301)
Japanisch
(67)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Trend in Cancer Incidence and Mortality in Fukushima From 2008 Through 2015

Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy

Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis

Evaluation of a novel medical device for pegfilgrastim administration

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial

Circulating cell-free DNA-based epigenetic assay can detect early breast cancer

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition

The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial

Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy

Characteristics of adverse events of endocrine therapies among older patients with breast cancer

Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood-Brain Barrier Models

Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial

Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition

Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan

Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells

CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study

Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β

Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer

Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study

Suchergebnisse filtern